Does this Glimpse Group (GGRP) insider report show any share purchases or sales?

No. The report shows only stock option awards , coded as acquisitions of derivative securities. There are no reported open-market purchases or sales of Glimpse Group common stock in this insider activity.

Glimpse Group (GGRP) grants stock options at $0.69 and $2.25

Q: What stock option grants did Charles Ian Morgan receive from Glimpse Group (GGRP)?

Charles Ian Morgan received two stock option awards from Glimpse Group. One grant covers 60,417 options on May 1, 2026, and another covers 37,500 options on January 1, 2025, both relating to Glimpse Group common stock.

Q: What are the exercise prices and expiration dates of the new GGRP options?

The May 1, 2026 grant has a $0.6900 exercise price, while the January 1, 2025 grant has a $2.2500 exercise price. Both option awards are scheduled to expire on May 31, 2031 , if not exercised earlier.

Q: How do the vesting schedules work for Charles Ian Morgan’s GGRP option awards?

The 60,417-option grant vested immediately upon grant on May 1, 2026. The 37,500-option grant vested in equal monthly increments from January 31, 2025 through December 31, 2025, spreading vesting across twelve months.

Q: Were the GGRP option awards to Charles Ian Morgan made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 trading plan checkbox was not marked for these transactions. The disclosure does not identify the option grants as being executed under a pre-arranged Rule 10b5-1 trading plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Charles Ian Morgan, a former director of Glimpse Group, Inc., received two stock option awards. On May 1, 2026 he was granted 60,417 stock options with a $0.6900 exercise price, expiring May 31, 2031, which vested immediately. On January 1, 2025 he was granted 37,500 stock options with a $2.2500 exercise price, also expiring May 31, 2031, vesting in equal monthly installments from January 31 through December 31, 2025. These transactions reflect option grants, with no reported share purchases or sales, and the Rule 10b5-1 trading plan box was not checked.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Charles Ian Morgan

Role Insider

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) ^F2	60,417	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) ^F1	37,500	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 97,917 shares (Direct)

Footnotes (2)

F1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.
F2. This option vested immediately upon grant.

Key Figures

Option grant shares (2026-05-01): 60,417 options Exercise price (2026-05-01 grant): $0.6900 per share Option grant shares (2025-01-01): 37,500 options +2 more

5 metrics

Option grant shares (2026-05-01) 60,417 options Stock Option (Right to Buy) granted to former director on May 1, 2026

Exercise price (2026-05-01 grant) $0.6900 per share Exercise price for 60,417 stock options granted May 1, 2026

Option grant shares (2025-01-01) 37,500 options Stock Option (Right to Buy) granted to former director on January 1, 2025

Exercise price (2025-01-01 grant) $2.2500 per share Exercise price for 37,500 stock options granted January 1, 2025

Option expiration date May 31, 2031 Expiration date for both option awards reported for Charles Ian Morgan

Key Terms

Stock Option (Right to Buy), exercise price, vested immediately upon grant, equal monthly increments

4 terms

Stock Option (Right to Buy) financial

"Security title is listed as "Stock Option (Right to Buy)" for both grants."

exercise price financial

"Each option award discloses a specified exercise price per share of common stock."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested immediately upon grant financial

"One footnote states that the option "vested immediately upon grant.""

equal monthly increments financial

"A footnote explains vesting occurs in "equal monthly increments" over 2025."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/27/2026 - 04:17 PM Accepted by SEC EDGAR 07/27/2026 - 04:16 PM

FAQ

What stock option grants did Charles Ian Morgan receive from Glimpse Group (GGRP)?

Charles Ian Morgan received two stock option awards from Glimpse Group. One grant covers 60,417 options on May 1, 2026, and another covers 37,500 options on January 1, 2025, both relating to Glimpse Group common stock.

What are the exercise prices and expiration dates of the new GGRP options?

The May 1, 2026 grant has a $0.6900 exercise price, while the January 1, 2025 grant has a $2.2500 exercise price. Both option awards are scheduled to expire on May 31, 2031, if not exercised earlier.

How do the vesting schedules work for Charles Ian Morgan’s GGRP option awards?

The 60,417-option grant vested immediately upon grant on May 1, 2026. The 37,500-option grant vested in equal monthly increments from January 31, 2025 through December 31, 2025, spreading vesting across twelve months.

Were the GGRP option awards to Charles Ian Morgan made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 trading plan checkbox was not marked for these transactions. The disclosure does not identify the option grants as being executed under a pre-arranged Rule 10b5-1 trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charles Ian Morgan

(Last)

(First)

(Middle)

15 WEST 38TH ST

12TH FLOOR

(Street)

NEW YORK

10018

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Glimpse Group, Inc. [ GGRP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director		10% Owner
Officer (give title below)	X	Other (specify below)
		Former director

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$2.25	01/01/2025		A		37,500		⁽¹⁾	05/31/2031	Common Stock	37,500	$0	37,500	D
Stock Option (Right to Buy)	$0.69	05/01/2026		A		60,417		⁽²⁾	05/31/2031	Common Stock	60,417	$0	60,417	D

Explanation of Responses:

1. This option vested in equal monthly increments from 1/31/2025 through 12/31/2025.

2. This option vested immediately upon grant.

	/s/ Ian Morgan Charles	07/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR